Our client—a clinical-stage genomic medicine company—recently achieved a major regulatory milestone for its lead gene therapy program targeting a rare lysosomal storage disorder. Following positive clinical trial data, the FDA has aligned with the company on an Accelerated Approval pathway, using an intermediate clinical endpoint as the basis for submission. A Biologics License Application (BLA) is expected in 2026. Recent regulatory meetings have also clarified the Chemistry, Manufacturing, and Controls.
Our client is seeking a mission-driven and scientifically grounded Sr. Director to lead the formulation, MSAT, and fill / finish operations for late-stage gene therapy drug products. This leader will drive execution across formulation development, technology transfer, CDMO management, and regulatory readiness.
Key Responsibilities
Key Requirements
Willingness to be onsite most days and flexible to travel between multiple locations in the San Francisco Bay Area.
Application Instructions :
https : / / nwrp.catsone.com / careers / 2072-General / jobs / 166933
Target Pay Range : $265,000 - $312,000 per year
The anticipated salary range is for candidates who will work in the San Francisco Bay Area work locations. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience with the job, type and length of experience within the industry, education, etc. The salary range may not apply to remote positions that work in other states.
J-18808-Ljbffr
#J-18808-Ljbffr